CTOs on the Move

Health Partners

www.healthpart.com

 
Health Partners, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Health Partners, Inc. is based in Philadelphia, PA. You can find more information on Health Partners, Inc. at www.healthpart.com
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

NeuroPace

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Rockford Health System

Rockford Health System is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Owensboro Medical Health System

Owensboro Medical Health System provides healthcare services to a ten-county area in Southern Indiana and Western Kentucky with a mission of healing the sick and improving the health of the community.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

PickMeUp Services

PickMeUp Services is a Orem, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.